The Pfizer-BioNTech COVID-19 vaccine may sometimes cause no side effects or mild-to-moderate side effects, which can be fairly common post-vaccination.
Read more
Home »
k1_otherviralinfections
1 year of COVID-19: A doctor's perspective
On March 11, 2020, the World Health Organization (WHO) officially declared COVID-19 a pandemic. As we approach the 1-year mark,
Read more
AstraZeneca vaccine: 3-month dosage interval might be preferable
The efficacy of some COVID-19 vaccines relies on having two doses within a certain amount of time. The government of
Read more
Is it ethical to continue COVID-19 vaccine trials?
The recent authorization of two highly effective COVID-19 vaccines for emergency use in the United States poses an ethical dilemma
Read more
In Conversation: Volunteering for a COVID-19 vaccine trial
Nathan volunteered for a COVID-19 vaccine clinical trial. Lindsay is a pharmacist and the drug content integrity manager at Healthline
Read more
COVID-19: Which interventions reduce transmission?
In a new study, scientists develop an equation that can help determine the likely number of people contracting SARS-CoV-2 from
Read more
How does risk vary for Black and Asian patients with COVID-19?
New research suggests that people of Black, mixed, and Asian ethnicity are more at risk of COVID-19, but these risks
Read more
Influenza drug shows promise against SARS-CoV-2
Researchers have found that high doses of a drug called favipiravir strongly inhibit SARS-CoV-2 in hamsters. Favipiravir also prevented infection
Read more
United Kingdom: Excess cardiovascular deaths during pandemic revealed
A new study reveals the number of excess cardiovascular deaths during the first peak of the pandemic in England and
Read more
No evidence of ‘cytokine storm’ in COVID-19
A study of COVID-19 patients in the Netherlands did not find the disease to be associated with cytokine storm, as
Read more